Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Bionor Pharma ApS
APS
In liquidation
CVR 36445564
Strandvejen 100
Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100
Est. 2014
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2016
DKK 7,9M
EBITDA margin
25.8%
+97% vs 2015
Equity ratio
91.9%
Financial strength
Net profit 2016
DKK 725K
+5% vs 2015
EBITDA — year on year
DKK millions
0M
1M
1M
2M
3M
1M
2015
2M
+100%
2016
Key figures
Annual report 2016
Revenue
DKK 7,9M
—
EBITDA
DKK 2M
+97%
Net profit
DKK 725K
+5%
Total assets
DKK 4,8M
-23%
Equity
DKK 4,4M
+20%
Employees
1
—
Company information
Legal name
Bionor Pharma ApS
CVR number
36445564
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
15. november 2014
Share capital
DKK 1.000.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2016-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Strandvejen 100
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Forskning og eksperimentel udvikling indenfor bioteknologi
Companies in Gentofte
All Denmark companies
Revenue
DKK millions
0M
2M
5M
7M
9M
0M
2015
8M
2016
EBITDA
DKK millions
0M
1M
1M
2M
2M
1M
2015
2M
2016
Income statement
DKK thousands
Item
2015
2016
Revenue
—
7.876
Staff expenses
-5.692
-5.845
EBITDA
1.033
2.032
Depreciation & amort.
-120
-1.092
EBIT
913
940
Net financials
-15
-4
Profit before tax
897
936
Tax
209
211
Net profit
688
725
Balance sheet
DKK thousands
Item
2015
2016
Total assets
6.189
4.790
Equity
3.677
4.402
Long-term debt
0
0
Short-term debt
2.474
388
Total debt
2.474
388
Financial ratios
5-year trend
EBITDA margin
25.8%
This company
15.8%
Market median
+63% vs market
2015
2016
Equity ratio
91.9%
This company
38.2%
Market median
+141% vs market
2015
2016
Return on equity
16.5%
This company
18.4%
Market median
+10% vs market
2015
2016
Net profit margin
9.2%
This company
8.1%
Market median
+14% vs market
2015
2016
Asset turnover
1.64×
This company
1.12×
Market median
+46% vs market
2015
2016
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
2015
2016
Annual reports & filings
Annual report 2016
Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
View
PDF
Annual report 2015
Filed via CVR / Virk · Period 2014-11-15 – 2015-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
DH
David Horn Solomon
Management
Management
2015
—
—
PA
Peter Andreas Stakemann
Management
Management
2014
—
—
RM
Regina Møller Andersen
Unofficial title
Unofficial title
2016
—
—
UH
Unni Hjelmaas
Chief Executive Officer
Chief Executive Officer
2016
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
GA
Gunnar Arne Flåten
Board of Directors
2015
—
—
TJ
Thomas Jeffrey Malherbes Gullacksen
Chairman
2014
—
—
SV
Søren Vitfell Keller
Board of Directors
2015
—
—
UL
Ulf Lund
Board of Directors
2014
—
—
PT
Per-Sveno Thoresen
Chairman
2016
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Bionor Pharma ASA
Individual
100.0%
100.0%
2015
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Bionor Pharma ApS also hold positions in
0
other companies.
Person
Role here
Other companies
David Horn Solomon
Management
0 companies
Peter Andreas Stakemann
Management
0 companies
Regina Møller Andersen
Unofficial title
0 companies
Unni Hjelmaas
Chief Executive Officer
0 companies
Gunnar Arne Flåten
Board of Directors
0 companies
Thomas Jeffrey Malherbes Gullacksen
Chairman
0 companies
Søren Vitfell Keller
Board of Directors
0 companies
Ulf Lund
Board of Directors
0 companies
Per-Sveno Thoresen
Chairman
0 companies